10times
05 - 06 May 2021Ended

Chronic Hepatitis B Drug Development Summit

AboutSpeakersExhibitorsReviewsPhotos

Estimated Turnout

upto 100
Delegates
Based on previous editions

Editions

May 2021

Frequency

Not Available
Claim event to edit details

The first ever conference purpose-built for discussing the advancement of curative therapies for chronic HBV infection. Traditional antiviral .. Read more approaches meet next-generation immunotherapy at this industry-led assembly of biotech and pharma leaders. Since the successful design and delivery of a functional cure for HCV in the form of a novel DAA combination; HBV has been brought to the centre stage. This action packed two day agenda holds 13 Presentations from industry and academic leaders, 2 interactive panel/roundtable discussions, one interactive HCC workshop and over 4 hours of networking, you can join the only platform discussing issues present in the development of curative HBV therapeutics. 13 Presentations from industry and academic leaders, 2 interactive panel/roundtable discussions, one interactive HCC workshop and over 4 hours of networking,.

  • Share your Experience
  • Organizer
Logo Follow Company

Hanson Wade Limited

UK364 Total Events / 52 Upcoming Events103+ Followers

More Events From The Organizer